You are here: Industry Insights > FDA

News List

Artificial pancreas for type 1 diabetes control given nod by FDA europeanpharmaceuticalreview
August 28, 2020
The all-in-one, Control-IQ system controlled the blood glucose levels of children aged six and over more successfully than standard technologies in a clinical trials.
FDA Removes Amputation Boxed Warning for Canagliflozin americanpharmaceuticalreview
August 28, 2020
Based on a U.S. Food and Drug Administration (FDA) review of new data from three clinical trials, the FDA has removed the Boxed Warning about amputation risk from the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) prescribing ...
Cassiopea secures FDA approval for Winlevi topical acne treatment pharmaceutical-technology
August 28, 2020
Italian speciality pharmaceutical firm Cassiopea has received approval from the US Food and Drug Administration (FDA) for Winlevi (clascoterone cream 1%) as a topical treatment for acne vulgaris.
Dr Reddy’s Laboratories launches penicillamine capsules in US expresspharma
August 28, 2020
It is a chelating agent used in the treatment of Wilson’s disease and to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis.
Alembic Pharma gets tentative nod from USFDA for Empagliflozin and Linagliptin tablets expresspharma
August 28, 2020
Empagliflozin and Linagliptin tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Aleor Dermaceuticals receives USFDA nod for Desonide lotion expresspharma
August 27, 2020
It indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
FDA's emergency nod for convalescent plasma sparks questions of whether it's bowing to Trump fiercepharma
August 26, 2020
Hospitalized COVID-19 patients in the U.S. have another treatment option in the U.S. after the FDA’s emergency authorization for convalescent plasma on Sunday.
FDA faces a reputation crisis amid Trump pressure for fast COVID action—and that's bad news for pharma fiercepharma
August 26, 2020
Critics are slamming the FDA and Commissioner Stephen Hahn for authorizing COVID-19 plasma treatment prematurely, but the issue is much broader than one emergency use authorization. The agency's reputation is on the line.
FDA chief Hahn walks back plasma claims, but his correction still missed the mark, experts say fiercepharma
August 26, 2020
With the emergency use authorization (EUA) for convalescent plasma to treat COVID-19, the FDA and Commissioner Stephen Hahn, M.D., touched off a controversy—particularly about his presentation of the evidence and the political pressure from the White Hous
FDA issues emergency use authorisation for COVID-19 convalescent plasma europeanpharmaceuticalreview
August 26, 2020
The emergency use authorisation (EUA) allows the distribution and administration of COVID-19 convalescent plasma to hospitalised patients in the US.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 367 368 Next page